AbCellera Biologics (ABCL) Payables (2020 - 2023)
AbCellera Biologics' (ABCL) quarterly Payables came in at $35.7 million in Q3 2023, up 38.05% YoY from $25.9 million in Q3 2022, and down 31.85% on a QoQ basis from $52.4 million in Q2 2023.
AbCellera Biologics (ABCL) Payables (2020 - 2023) Analysis & Trends
AbCellera Biologics (ABCL) has 4 years of Payables data on file, last reported at $35.7 million in Q3 2023.
- Quarterly Payables rose 38.05% year-over-year to $35.7 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $35.7 million (up 38.05% YoY) and the FY2022 annual result came in at $33.2 million, up 3.54% from the prior year.
- Payables eased to $35.7 million in Q3 2023, from $52.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $52.4 million in Q2 2023 to a low of $13.3 million in Q1 2021.
- A 4-year average of $28.1 million and a median of $25.8 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables grew 3.54% — and 2023, when it soared 114.82%.
- Tracing ABCL's Payables over 4 years: stood at $20.2 million in 2020, then surged by 58.54% to $32.0 million in 2021, then gained by 3.54% to $33.2 million in 2022, then climbed by 7.72% to $35.7 million in 2023.
- The last three Payables figures came in at $35.7 million (Q3 2023), $52.4 million (Q2 2023), and $31.8 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 35.71 Mn |
| Jun 30, 2023 | 52.40 Mn |
| Mar 31, 2023 | 31.81 Mn |
| Dec 31, 2022 | 33.15 Mn |
| Sep 30, 2022 | 25.87 Mn |
| Jun 30, 2022 | 24.39 Mn |
| Mar 31, 2022 | 25.72 Mn |
| Dec 31, 2021 | 32.02 Mn |
| Sep 30, 2021 | 24.07 Mn |
| Jun 30, 2021 | 18.28 Mn |
| Mar 31, 2021 | 13.29 Mn |
| Dec 31, 2020 | 20.20 Mn |